Exhibit 107

Calculation of Filing Fee Tables

Form S-3

(Form Type)

LENZ Therapeutics, Inc.

(Exact Name of Registrant as Specified in its Charter)

Table 1: Newly Registered Securities

Security Type

Security Class

Fee Calculation Rule

Amount Registered(1)(2)

Proposed Maximum Offering Price Per Unit(3)

Maximum Aggregate Offering Price(3)

Fee Rate

Amount of Registration Fee

Fees to be Paid

Equity

Common Stock, $0.00001 par value per share

457(c)

13,070,093

$23.87

$311,983,119.91

0.00015310

$47,764.62

Total Offering Amounts

$311,983,119.91

$47,764.62

Total Fees Previously Paid

$0

Net Fee Due

$47,764.62

(1)    Pursuant to Rule 416(a) of the Securities Act of 1933, as amended, this registration statement shall also cover any additional shares of the registrant’s common stock that become issuable by reason of any stock dividend, stock split, recapitalization or other similar transaction effected without receipt of consideration that increases the number of the registrant’s outstanding shares of common stock.

(2)    This registration statement registers 12,922,451 outstanding shares of common stock of the registrant and 147,642 shares of common stock of the registrant issuable upon the exercise of warrants issued by the registrant.

(3)    Estimated solely for the purpose of calculating the registration fee according to Rule 457(c) under the Securities Act of 1933, as amended, based on the average of the high ($24.90) and low ($22.84) prices of the registrant’s common stock reported on the Nasdaq Global Select Market on April 3, 2025, which is within five business days prior to filing this registration statement.